Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MICRO-ultrasound Guided Prostate SBRT

NCT: NCT07737457 · NOT_YET_RECRUITING

NCT IDNCT07737457
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2033-03
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (OTHER)
First posted
Last updated

Brief Summary

This study will test whether it is safe and effective to use stereotactic body radiation therapy (SBRT)-a short, targeted form of radiation-together with a microultrasound (microUS)-guided radiation boost to the cancerous spots inside the prostate. Researchers will compare treatment plans that use microUS to plans created using the current standard method, which relies on MRI images, to determine whether microUS can successfully guide targeted radiation.

Frequently Asked Questions

What is MICRO-ultrasound Guided Prostate SBRT?

MICRO-ultrasound Guided Prostate SBRT is a clinical trial registered under NCT07737457. Current status: NOT_YET_RECRUITING.

What is the status of NCT07737457?

The current status of NCT07737457 (MICRO-ultrasound Guided Prostate SBRT) is: NOT_YET_RECRUITING.

When did MICRO-ultrasound Guided Prostate SBRT start?

MICRO-ultrasound Guided Prostate SBRT started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑